Royal Bank Of Canada set a $41.00 target price on Mylan N.V. (NASDAQ:MYL) in a report published on Sunday, July 16th. The brokerage currently has a hold rating on the stock.
MYL has been the subject of a number of other reports. Barclays PLC upgraded shares of Mylan N.V. from an equal weight rating to an overweight rating and raised their price target for the stock from $47.00 to $50.00 in a report on Monday, May 22nd. BMO Capital Markets initiated coverage on shares of Mylan N.V. in a report on Monday, May 1st. They issued an outperform rating and a $50.00 price target for the company. Mizuho restated a buy rating and issued a $53.00 price target on shares of Mylan N.V. in a report on Thursday, March 30th. Wells Fargo & Co restated a market perform rating and issued a $40.00 price target on shares of Mylan N.V. in a report on Friday, April 14th. Finally, Leerink Swann reaffirmed an outperform rating and issued a $52.00 price objective on shares of Mylan N.V. in a research note on Thursday, March 30th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus price target of $50.92.
Mylan N.V. (NASDAQ:MYL) opened at 32.92 on Friday. The company has a 50 day moving average price of $38.42 and a 200 day moving average price of $39.28. The firm has a market cap of $17.64 billion, a PE ratio of 32.89 and a beta of 1.27. Mylan N.V. has a 1-year low of $32.77 and a 1-year high of $50.40.
Mylan N.V. (NASDAQ:MYL) last posted its quarterly earnings data on Wednesday, May 10th. The company reported $0.93 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.92 by $0.01. Mylan N.V. had a net margin of 4.59% and a return on equity of 23.69%. The company had revenue of $2.72 billion during the quarter, compared to analysts’ expectations of $2.81 billion. During the same period in the prior year, the company posted $0.76 earnings per share. Mylan N.V.’s revenue for the quarter was up 24.1% compared to the same quarter last year. On average, equities research analysts forecast that Mylan N.V. will post $5.16 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: “Mylan N.V. (MYL) Given a $41.00 Price Target at Royal Bank Of Canada” was originally reported by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this article on another website, it was copied illegally and republished in violation of U.S. and international copyright legislation. The original version of this article can be accessed at https://stocknewstimes.com/2017/08/06/mylan-n-v-myl-given-a-41-00-price-target-by-royal-bank-of-canada-analysts-updated-updated.html.
In related news, President Rajiv Malik sold 25,000 shares of the stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $1,000,000.00. Following the sale, the president now directly owns 799,855 shares of the company’s stock, valued at approximately $31,994,200. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Anthony Mauro sold 10,000 shares of the stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $400,000.00. Following the sale, the insider now directly owns 140,653 shares in the company, valued at $5,626,120. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by insiders.
Institutional investors have recently bought and sold shares of the stock. Cleararc Capital Inc. boosted its position in Mylan N.V. by 0.6% in the first quarter. Cleararc Capital Inc. now owns 10,394 shares of the company’s stock valued at $405,000 after buying an additional 67 shares in the last quarter. Conning Inc. boosted its position in Mylan N.V. by 1.3% in the first quarter. Conning Inc. now owns 10,128 shares of the company’s stock valued at $395,000 after buying an additional 130 shares in the last quarter. Sei Investments Co. boosted its position in Mylan N.V. by 1.0% in the first quarter. Sei Investments Co. now owns 13,870 shares of the company’s stock valued at $541,000 after buying an additional 134 shares in the last quarter. Bank of Nova Scotia boosted its position in Mylan N.V. by 1.9% in the first quarter. Bank of Nova Scotia now owns 10,525 shares of the company’s stock valued at $410,000 after buying an additional 196 shares in the last quarter. Finally, Wade G W & Inc. boosted its position in Mylan N.V. by 3.6% in the first quarter. Wade G W & Inc. now owns 6,156 shares of the company’s stock valued at $240,000 after buying an additional 213 shares in the last quarter. Institutional investors and hedge funds own 69.86% of the company’s stock.
Mylan N.V. Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.
